There’s always something new to learn! Staying curious throughout your life is a great way to keep your mind sharp and avoid ...
Zealand Pharma announces positive Phase 1a topline results with Kv1.3 channel blocker ZP9830 Single doses of ZP9830 were well tolerated, with no serious or severe adverse events or dose-limiting ...
- Company to hold conference call and webcast at 8:30 a.m. ET today Evommune, Inc. (NYSE: EVMN) (the “Company” or “Evommune”), a clinical-stage biotechnology company developing innovative therapies ...
Singer-songwriter and three-time Grammy-winner Olivia Rodrigo became the fourth recipient of the Universal Music Group x Reverb Amplifier Award, recognizing “her outstanding commitment to driving ...
Shares of Corvus Pharmaceuticals rose after its investigational drug soquelitinib showed positive results in an early-stage trial in atopic dermatitis patients. The stock surged 50% to $12.10 in ...
COLUMBUS, Ohio--(BUSINESS WIRE)--Clarametyx Biosciences, Inc. (“Clarametyx”), a clinical-stage biotechnology company developing immune-enabling therapies and vaccines to address biofilm-driven chronic ...
Study met its primary endpoint demonstrating safety and tolerability of CMTX-101 in people with cystic fibrosis CMTX-101 treatment produced clinically meaningful reductions in key inflammatory ...
Johnson & Johnson announced positive topline results from its Phase 2 randomized placebo-controlled JASMINE study. The drug therapy, nipocalimab, met its primary endpoint and multiple key secondary ...
An update from DBV Technologies SA – American ( (DBVT)) is now available. On December 16, 2025, DBV Technologies announced positive topline results from its Phase 3 VITESSE trial of the VIASKIN® ...
At the San Antonio Breast Cancer Symposium (SABCS), investigators reported final phase I results of an alpha-lactalbumin (aLA) vaccine designed to help prevent triple-negative breast cancer (TNBC), ...
Zymeworks Inc. (ZYME) surged after positive Phase 3 results for Ziihera in first-line HER2-positive gastroesophageal adenocarcinoma, expanding its FDA-approved indications. ZYME's partnership-driven ...
This power-management tip introduces the two different circuits for a positive-to-negative voltage conversion and a negative-to-positive voltage conversion. However, there are times when a voltage ...